Concerns about MRSA for expectant mothers may be unfounded

April 19, 2012 By Craig Boerner
Natalia Jimenez-Truque, MSCI, and Buddy Creech, M.D., MPH, are studying the ramifications of expectant mothers passing MRSA to their children. Credit: Anne Rayner

The need to swab the noses of pregnant women and newborns for the presence of MRSA (methicillin-resistant Staphylococcus aureus) may be unfounded, according to a Vanderbilt study now available online and published in the May issue of Pediatrics.

The study’s senior author, Buddy Creech, M.D., MPH, assistant professor of Pediatrics, said it is often feared that mothers carrying MRSA may risk transmitting an infection to their newborn , but Vanderbilt Pediatric Infectious Diseases researchers found that babies rarely became ill from MRSA infections, despite frequently carrying the germ.

“Describing the timing and mode of transmission is important, since the most critical finding in this research is that babies are very commonly exposed to MRSA in early infancy, often with strains that aren't likely to cause disease,” Creech said.

The study enrolled more than 500 pregnant women in Nashville and Memphis. Nasal and vaginal swabs were collected and tested for the presence of bacteria at regular intervals, including at the time of delivery. Babies were swabbed right after birth and at 2 and 4 months of age.

Results show little vertical transmission of MRSA from mother to child, Creech said, but babies did closely match their mother’s carrier status by 2 months of age. This suggests a mother who carries S. aureus bacteria in her nose will give it to her baby and her baby will become colonized from close contact within six to eight weeks after birth, which is called horizontal transmission.

“Labs were finding a substantial amount of MRSA. Even in our study we found 20 percent of will have it, as will 20 percent of babies at eight weeks,” Creech said. “But there is tremendous anxiety about what that means and, for physicians, what do you do?”

“We don’t want to overreact to carriage when incidence of disease is low. A lot of babies are colonized. A lot. Twenty percent at 2 months of age is the highest rate we’ve ever seen, but in our study only two babies got disease,” Creech said.

Creech says, at this time, the best action when MRSA colonization is detected in a pregnant woman may be no action at all.

The next step in research is to determine if mother-to-child transmission of MRSA in infancy might provide benefits, like greater protection against more serious MRSA illnesses later in life.

The study’s first author is Natalia Jimenez-Truque, MQC, MSCI, Epidemiology graduate student in Pediatric Infectious Diseases.

Explore further: Coffee and tea consumption reduce MRSA risk

Related Stories

Coffee and tea consumption reduce MRSA risk

July 15, 2011

While an apple a day may keep the doctor away, new research published in the Annals of Family Medicine say that hot tea or coffee may keep the methicillin-resistant Staphyloccus aureus, or MRSA, bug away, or at least out ...

Recommended for you

Bile acid uptake inhibitor prevents NASH / fatty liver in mice

September 21, 2016

Drugs that interfere with bile acid recycling can prevent several aspects of NASH (nonalcoholic steatohepatitis) in mice fed a high-fat diet, scientists from Emory University School of Medicine and Children's Healthcare of ...

New therapeutic target for Crohn's disease

September 20, 2016

Research from the Sanford Burnham Prebys Medical Discovery Institute (SBP) identifies a promising new target for future drugs to treat inflammatory bowel disease (IBD). The study, published today in Cell Reports, also indicates ...

Mosquitoes, Zika and biotech regulation

September 19, 2016

In a new Policy Forum article in Science, NC State professor Jennifer Kuzma argues that federal authorities are missing an opportunity to revise outdated regulatory processes not fit for modern innovations in biotechnology, ...

Arthritis drug may help with type of hair loss

September 22, 2016

(HealthDay)—For people who suffer from a condition that causes disfiguring hair loss, a drug used for rheumatoid arthritis might regrow their hair, a new, small study suggests.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.